NEUE neuehealth.com: Forward P/S Multiple

Corporate company logo of neuehealth.com (NEUE)

NeueHealth, Inc. (NEUE) is fighting for survival amidst the aggressive dominance of industry behemoths. The forward P/S ratio reflects the immediate market reaction, with the 0.10 metric serving as the target level. While the company's capital relies on Medicare and insurance services, the business is currently pivoting toward primary care to overcome the aftermath of previous financial difficulties.

NeueHealth - NEUE Market Cap to Future Revenue Ratio (period 02/21/2024 - 10/18/2025)

neuehealth.com (NEUE) - metric breakdowns and financial figures

- current price and projected stock value:
Stock Price NeueHealth|NEUE - Average Forecast Price
- company stock capitalization data:
Market Capitalization NeueHealth, Inc.|NEUE - Value Adjusted for Debt and Cash
- issuer book value statistics:
Book Value per Share NeueHealth|NEUE - Total Stockholders' Equity|Market Capitalization to Book Value Ratio neuehealth.com|NEUE - Company Total Assets
- debt and solvency information:
Debt to Equity NeueHealth, Inc.|NEUE - Long-Term Debt to Equity|Short-Term Debt to Equity Ratio NeueHealth|NEUE - Company Cumulative Indebtedness|Debts to Book Capitalization NeueHealth, Inc.|NEUE - Company Long-Term Loans and Borrowings|Company Current Liabilities NeueHealth|Quick Ratio neuehealth.com
- financial results and valuation multiples details:
NEUE - Net Financial Result|Expected Profit NeueHealth, Inc.|NEUE - Price to Earnings Multiple|Forward P/E Multiple NeueHealth|NEUE - Price/Earnings to Growth Multiple|Enterprise Value to EBITDA Ratio NeueHealth, Inc.|NEUE - Operating income before deduction of amortization|Earnings per share for the last twelve months NeueHealth|NEUE - Earnings per share for the last 12 months|Quarterly EPS earnings growth neuehealth.com|NEUE - Earnings per share growth rate in current year|Expected earnings per share growth for next year NeueHealth, Inc.
- revenue and sales details:
NEUE - Revenue and Sales Volume|Projected Sales Volume NeueHealth|NEUE - Price to Sales|Price-to-Projected Revenue Ratio NeueHealth, Inc.
General company analysis:NeueHealth Corp NEUE
Original product of NeueHealth Inc.

The ratio's dynamics depend on management's ability to curb medical inflation to maintain operating margins. This forward P/S valuation metric compares the current market value of NeueHealth, Inc. (NEUE) with expected sales volume, which, given the defensive nature of the insurance business, allows investors to assess the premium paid for stable cash flows by analyzing this chart.

Key competitors

Forward P/S Multiple UNH (UnitedHealth)|Cigna Healthcare (CI) - Market Cap to Future Revenue Ratio|Aflac Insurance - Forward P/S Multiple|Forward Price to Sales HUM (Humana Corp)|CNC: Forward P/S Multiple|Market Cap to Future Revenue Ratio molinahealthcare.com (MOH)|MMS (Maximus) - Forward P/S Multiple|Forward P/S Multiple Oscar|Price-to-Projected Revenue Ratio Clover Health Corp (CLOV)|Price-to-Projected Revenue Ratio CTEV (Claritev Health)|Yuanbao Inc. - Forward Price-to-Revenue Multiple|Price to Expected Revenue Ratio HIT (Health In Tech Inc.)|eHealth Insurance - Forward P/S Multiple|Forward Price to Sales GOCO (GoHealth Inc.)|RELI (Reliance Global) - Forward Price-to-Revenue Multiple|MSP Recovery Corp - Forward Price to Sales|MPLN (MultiPlan Corporation) - Forward P/S Multiple